First nonhormonal treatment for hot flashes, Brisdelle, approved by FDA

First nonhormonal treatment for hot flashes, Brisdelle, approved by FDA

In March, the FDA's independent advisory committee voted not to approve Brisdelle and another nonhormonal treatment, Depomed, on the grounds that they did not offer sufficient benefit. RELATED: ESTROGEN PLAYS KEY ROLE IN REVVING WOMEN'S 

7
Like
Save

Comments

Write a comment

*